Drawing for RARE DISEASE SUMMIT USA

USPTO serial 99488165

RARE DISEASE SUMMIT USA

Status 602
Filing date
Nov 10, 2025
Status date
Jul 28, 2026
Registration date
Examiner
CROWLEY, SEAN MICHAEL

Need help with RARE DISEASE SUMMIT USA?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Owner

  • Prescribe Plus LLC

    Charlotte, NC, US

Goods and services

ClassDescriptionStatusFirst use
035Event marketing; Special event planning for business purposes; Special event planning for commercial, promotional or advertising purposes; Consultation in the field of special event planning for commercial purposes; Event management services being organising and conducting of marketing promotional events; Event management services being organizing and conducting of commercial trade shows; Event management services being arranging and conducting of commercial trade shows; Event management services being organising and conducting of commercial trade shows; Event management services being organizing and conducting of marketing promotional events; Consultation in the field of special event planning for commercial or marketing purposes; Conducting of commercial events in the nature of trade shows; Arranging of commercial events in the nature of trade shows; Organizing, promoting and conducting exhibitions, tradeshows and events for business purposes; Event management services being organizing and conducting of commercial trade show events; Conducting, arranging and organizing trade shows and trade fairs for commercial and advertising purposes; Conducting trade shows in the field of healthcareACTIVEApr 1, 2025

Prosecution history

DateCodeEvent
Jul 28, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 28, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 13, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 13, 2026GNRTNON-FINAL ACTION E-MAILED
Apr 13, 2026CNRTNON-FINAL ACTION WRITTEN
Mar 20, 2026DOCKASSIGNED TO EXAMINER
Feb 12, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 10, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Nov 10, 2025NWAPNEW APPLICATION ENTERED

Related guidance